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Trichosporon species have become increasingly
recognized as opportunistic pathogens capable of
causing disseminated infections. Cutaneous lesions
are fairly common andmay serve as a diagnostic clue
to invasive Trichosporon infection. We report a case
of disseminated trichosporonosis in an immunocom-
promised patient who presented with purpuric and
cream-colored plaques.CASE REPORT
A 67-year-old man with insulin-dependent
diabetes mellitus and chronic kidney disease was
admitted to the hospital for perforated ischemic
colitis requiring exploratory laparotomy and partial
colectomy. He was taking tacrolimus and methyl-
prednisolone for immunosuppression for a cardiac
transplantation 8 years ago. His hospital course was
complicated by ventilator-dependent respiratory
failure, and he was given broad-spectrum antimicro-
bials, including meropenem, vancomycin, and cas-
pofungin, for culture-negative fevers. Approximately
4 weeks into his hospitalization, he had cream-
colored plaques with surrounding stellate purpura
and necrosis on the right medial thigh and scrotum
and multiple blue-black bullous plaques on the
right foot (Fig 1). Laboratory testing found a white
blood cell count of 18,600/L (reference range
4,000e11,000/L), hemoglobin of 8.3 g/dL (refe-
rence range, 13.5e17.5 g/dL), and serum creatinine
of 2.38 mg/dL (reference range, 0.64e1.27 mg/dL).
A bedside potassium hydroxide preparation
performed from the right thigh lesion found fungal
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Case Reports 2016;2:275-7.standard skin biopsy, and tissue cultures were also
performed. The skin biopsy found acute necrotizing
inflammation, hemorrhage, and deep fungal infec-
tion in the skin and subcutis, with pleomorphic yeast
and hyphae forms highlighted on Periodic
AcideSchiff and Grocott stains (Fig 2, B).
Trichosporon asahii was isolated from skin tissue
culture and subsequently from respiratory and
blood cultures. Fungal culture plates found
characteristic morphology of the yeast (Fig 2, C ),
which resembled the cream-colored plaques on the
patient’s skin.
The patient’s antifungal therapy was switched to
voriconazole and amphotericin, and his immuno-
suppressive medications were stopped. Despite
these measures, his condition continued to deterio-
rate, and he died a few days after diagnosis of the
disseminated infection.DISCUSSION
Trichosporon species are basidiomycetous yeasts
that areubiquitous in theenvironmentbut cancolonize
the gastrointestinal and urinary tracts, respiratory
airways, and skin.1 Although Trichosporon is
most commonly associated with white piedra,
a benign superficial infection of the hair, it has
become increasingly recognized as an opportunistic
pathogen capable of causing invasive and fatal infec-
tion.2 Trichosporon is the secondmost common cause,
after Candida, of disseminated yeast infection in
patients with hematologic malignancies.1 Of the 50
Trichosporon species classified to date, T asahii is the
most common cause of invasive infection, followed by
Trichosporon mucoides and Trichosporon asteroides.12352-5126
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Fig 1. Disseminated trichosporonosis. A, Cream-colored and purpuric plaque on the right
medial thigh. B, Necrotic bullae on the right foot.
Fig 2. A, Potassium hydroxide preparation. B, Punch biopsy with visible organisms (Grocott
stain; original magnification: 340). C, Fungal culture plate with Trichosporon. (Courtesy of
Laurel Glaser, MD, PhD.)
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nocompromised persons, particularly those with
hematologic malignancies or history of organ
transplantation.1-4 It has also been reported in
persons with AIDS and critically ill patients without
other underlying immunosuppression.1,5,6 While
exogenous inoculation may cause infection, such
as in catheter-associated cases, it has been theorized
that mucosal, including gut, colonization with
Trichosporon and subsequent translocation may
lead to deep-seated infection.1 Fungemia and fever
are the most common findings in disseminated
trichosporonosis. Approximately 30% of patients
subsequently have cutaneous lesions, which present
as red or purpuric papules, vesicles, and nodules,
often with necrosis or ulceration.6 Organs such as the
lung, liver, heart, brain, and urinary tract may also be
infected.
Early diagnosis of invasive trichosporonosis is
critical and can be made using tissue histology and
culture. Although limited data exist on the antifungal
susceptibilities of Trichosporon species, triazoles,
including voriconazole, appear to have the greatestactivity and are recommended as first-line ther-
apy.3,4,7 However, breakthrough Trichosporon
infections have been noted in patients even after
the administration of triazoles,1,7-9 and multiple
Trichosporon species can produce triazole-resistant
biofilms.10 In addition, increasing evidence suggests
that amphotericin and echinocandins have little
to no efficacy against Trichosporon.1,8 Despite anti-
fungal therapy, invasive trichosporonosis carries a
mortality rate of 50% to 80%.1
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